These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22898077)

  • 21. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
    Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
    Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA; Stentz F; Gettys T; Smith SR
    Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations.
    Tian L; Fu M
    J Endocrinol Invest; 2011 Jun; 34(6):461-72. PubMed ID: 21747218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice.
    Weinstock PH; Bisgaier CL; Hayek T; Aalto-Setala K; Sehayek E; Wu L; Sheiffele P; Merkel M; Essenburg AD; Breslow JL
    J Lipid Res; 1997 Sep; 38(9):1782-94. PubMed ID: 9323588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 28. Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee.
    Wang W; Blackett P; Khan S; Lee E
    J Lipids; 2017; 2017():8236325. PubMed ID: 28473926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequences and expression of the porcine apolipoprotein A-I and C-III mRNAs.
    Trieu VN; Hasler-Rapacz J; Rapacz J; Black DD
    Gene; 1993 Jan; 123(2):173-9. PubMed ID: 8428656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.
    Jensen MK; Rimm EB; Furtado JD; Sacks FM
    J Am Heart Assoc; 2012 Apr; 1(2):. PubMed ID: 23130121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.
    Wyler von Ballmoos MC; Haring B; Sacks FM
    J Clin Lipidol; 2015; 9(4):498-510. PubMed ID: 26228667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study.
    Wang W; Lee ET; Alaupovic P; Blackett P; Blevins KS
    Ann Epidemiol; 2005 May; 15(5):390-7. PubMed ID: 15840553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes.
    Haddad IA; Ordovas JM; Fitzpatrick T; Karathanasis SK
    J Biol Chem; 1986 Oct; 261(28):13268-77. PubMed ID: 3020028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ApoA-IV metabolism in the rat: role of lipoprotein lipase and apolipoprotein transfer.
    Lefevre M; Chuang MY; Roheim PS
    J Lipid Res; 1986 Nov; 27(11):1163-73. PubMed ID: 3559382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver.
    Lin-Lee YC; Strobl W; Soyal S; Radosavljevic M; Song M; Gotto AM; Patsch W
    J Lipid Res; 1993 Feb; 34(2):249-59. PubMed ID: 8429259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and expression of dog apolipoprotein C-II and C-III mRNAs. Implications for the evolution and functional constraints of apolipoprotein structure.
    Datta S; Li WH; Ghosh I; Luo CC; Chan L
    J Biol Chem; 1987 Aug; 262(22):10588-93. PubMed ID: 2956259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice.
    Qu S; Perdomo G; Su D; D'Souza FM; Shachter NS; Dong HH
    J Lipid Res; 2007 Jul; 48(7):1476-87. PubMed ID: 17438339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.